These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 20012548

  • 21. Involvement of PPARalpha in the growth inhibitory effect of arachidonic acid on breast cancer cells.
    Bocca C, Bozzo F, Martinasso G, Canuto RA, Miglietta A.
    Br J Nutr; 2008 Oct; 100(4):739-50. PubMed ID: 18304389
    [Abstract] [Full Text] [Related]

  • 22. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
    Marampon F, Ciccarelli C, Zani BM.
    Mol Cancer; 2006 Aug 09; 5():31. PubMed ID: 16899113
    [Abstract] [Full Text] [Related]

  • 23. The expression of p53 tumor suppressor gene in breast cancer cells is down-regulated by cytokine oncostatin M.
    Liu J, Li C, Ahlborn TE, Spence MJ, Meng L, Boxer LM.
    Cell Growth Differ; 1999 Oct 09; 10(10):677-83. PubMed ID: 10547071
    [Abstract] [Full Text] [Related]

  • 24. Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis.
    Hagan S, Al-Mulla F, Mallon E, Oien K, Ferrier R, Gusterson B, García JJ, Kolch W.
    Clin Cancer Res; 2005 Oct 15; 11(20):7392-7. PubMed ID: 16243812
    [Abstract] [Full Text] [Related]

  • 25. The impact of altered annexin I protein levels on apoptosis and signal transduction pathways in prostate cancer cells.
    Hsiang CH, Tunoda T, Whang YE, Tyson DR, Ornstein DK.
    Prostate; 2006 Sep 15; 66(13):1413-24. PubMed ID: 16741918
    [Abstract] [Full Text] [Related]

  • 26. Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1.
    Chen C, Chang YC, Liu CL, Chang KJ, Guo IC.
    Breast Cancer Res Treat; 2006 Jul 15; 98(2):121-32. PubMed ID: 16752079
    [Abstract] [Full Text] [Related]

  • 27. Role of nongenomic activation of phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase 1/2 pathways in 1,25D3-mediated apoptosis in squamous cell carcinoma cells.
    Ma Y, Yu WD, Kong RX, Trump DL, Johnson CS.
    Cancer Res; 2006 Aug 15; 66(16):8131-8. PubMed ID: 16912191
    [Abstract] [Full Text] [Related]

  • 28. Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells.
    Fiucci G, Ravid D, Reich R, Liscovitch M.
    Oncogene; 2002 Apr 04; 21(15):2365-75. PubMed ID: 11948420
    [Abstract] [Full Text] [Related]

  • 29. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
    Dong K, Wang R, Wang X, Lin F, Shen JJ, Gao P, Zhang HZ.
    Breast Cancer Res Treat; 2009 Feb 04; 113(3):443-56. PubMed ID: 18327707
    [Abstract] [Full Text] [Related]

  • 30. Reactive oxygen species induce phosphorylation of serine 118 and 167 on estrogen receptor alpha.
    Weitsman GE, Weebadda W, Ung K, Murphy LC.
    Breast Cancer Res Treat; 2009 Nov 04; 118(2):269-79. PubMed ID: 18941890
    [Abstract] [Full Text] [Related]

  • 31. The ras/mitogen-activated protein kinase pathway inhibitor and likely tumor suppressor proteins, sprouty 1 and sprouty 2 are deregulated in breast cancer.
    Lo TL, Yusoff P, Fong CW, Guo K, McCaw BJ, Phillips WA, Yang H, Wong ES, Leong HF, Zeng Q, Putti TC, Guy GR.
    Cancer Res; 2004 Sep 01; 64(17):6127-36. PubMed ID: 15342396
    [Abstract] [Full Text] [Related]

  • 32. EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation.
    Yao W, Feng D, Bian W, Yang L, Li Y, Yang Z, Xiong Y, Zheng J, Zhai R, He J.
    Amino Acids; 2012 Nov 01; 43(5):2027-35. PubMed ID: 22476347
    [Abstract] [Full Text] [Related]

  • 33. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H, Groth J, Sossey-Alaoui K, Hawthorn L, Beall S, Geradts J.
    Clin Cancer Res; 2005 Jun 15; 11(12):4357-64. PubMed ID: 15958618
    [Abstract] [Full Text] [Related]

  • 34. Peripheral-type benzodiazepine receptor overexpression and knockdown in human breast cancer cells indicate its prominent role in tumor cell proliferation.
    Li W, Hardwick MJ, Rosenthal D, Culty M, Papadopoulos V.
    Biochem Pharmacol; 2007 Feb 15; 73(4):491-503. PubMed ID: 17126818
    [Abstract] [Full Text] [Related]

  • 35. [Function and prognostic value of tumor suppressor gene LKB1 in human breast carcinoma].
    Shen Z, Wu Q, Yue L, Li HC, Shen ZZ, Shao ZM.
    Zhonghua Yi Xue Za Zhi; 2005 Jan 05; 85(1):15-8. PubMed ID: 15808068
    [Abstract] [Full Text] [Related]

  • 36. Induction of apoptosis in MCF-7 and MDA-MB-231 breast cancer cells by Oligonol is mediated by Bcl-2 family regulation and MEK/ERK signaling.
    Jo EH, Lee SJ, Ahn NS, Park JS, Hwang JW, Kim SH, Aruoma OI, Lee YS, Kang KS.
    Eur J Cancer Prev; 2007 Aug 05; 16(4):342-7. PubMed ID: 17554207
    [Abstract] [Full Text] [Related]

  • 37. Tumor suppressor function of ezrin-radixin-moesin-binding phosphoprotein-50 through β-catenin/E-cadherin pathway in human hepatocellular cancer.
    Peng XL, Ji MY, Yang ZR, Song J, Dong WG.
    World J Gastroenterol; 2013 Feb 28; 19(8):1306-13. PubMed ID: 23483729
    [Abstract] [Full Text] [Related]

  • 38. Loss of EBP50 stimulates EGFR activity to induce EMT phenotypic features in biliary cancer cells.
    Clapéron A, Guedj N, Mergey M, Vignjevic D, Desbois-Mouthon C, Boissan M, Saubaméa B, Paradis V, Housset C, Fouassier L.
    Oncogene; 2012 Mar 15; 31(11):1376-88. PubMed ID: 21822312
    [Abstract] [Full Text] [Related]

  • 39. A novel role for insulin resistance in the connection between obesity and postmenopausal breast cancer.
    Weichhaus M, Broom J, Wahle K, Bermano G.
    Int J Oncol; 2012 Aug 15; 41(2):745-52. PubMed ID: 22614942
    [Abstract] [Full Text] [Related]

  • 40. Expression and clinicopathological significance of oestrogen-responsive ezrin-radixin-moesin-binding phosphoprotein 50 in breast cancer.
    Song J, Bai J, Yang W, Gabrielson EW, Chan DW, Zhang Z.
    Histopathology; 2007 Jul 15; 51(1):40-53. PubMed ID: 17593079
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.